Thermo Fisher introduces new AcroMetrix COVID-19 RNA Control
Thermo Fisher has designed and developed the new synthetic RNA control to enable the labs validate and monitor…
01 Apr 20
Thermo Fisher has designed and developed the new synthetic RNA control to enable the labs validate and monitor…
01 Apr 20
The new diagnostic test, with 91% clinical specificity rate and a 99% clinical sensitivity rate, has been designed…
01 Apr 20
The point-of-care test will detect antibodies in blood to confirm current or past exposure to COVID-19 within 15…
31 Mar 20
Fluxergy's on-site sample-to-answer test needs a small sample for the detection of COVID-19 disease
31 Mar 20
The Ohio State Wexner Medical Center will conduct the new rapid test with its existing FDA certification permits
31 Mar 20
Through technology available on a number of smart devices, Sprint Covid-19 aims to measure users’ blood oxygen levels,…
30 Mar 20
The new NxTAG CoV extended panel is used with the company’s compact MAGPIX System, to detect SARS-CoV-2 virus…
30 Mar 20
The test is said to deliver accuracy rate between 89% and 91%, as it relies on the level…
30 Mar 20
The two companies ICU Eyewear and Contour Optik are also donating 100,000 face masks and 50,000 face shields…
Patient Care DevicesPatient Care MonitoringDiagnostic Devices
27 Mar 20
Thermo Fisher’s COVID-19 diagnostic test has been designed to deliver patient results within four hours